{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:26:11Z","timestamp":1790670371760,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":307,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.toxrep.2021.11.003","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T21:55:57Z","timestamp":1636149357000},"page":"1846-1848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report"],"prefix":"10.1016","volume":"8","author":[{"given":"Suthimon","family":"Thumtecho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6306-0930","authenticated-orcid":false,"given":"Sorawit","family":"Wainipitapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchai","family":"Suteparuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2021.11.003_bib0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/15563650701382789","article-title":"Human poisoning in Thailand: the Ramathibodi Poison Center\u2019s experience (2001\u20132004)","volume":"45","author":"Wananukul","year":"2007","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.toxrep.2021.11.003_bib0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"issue":"23","key":"10.1016\/j.toxrep.2021.11.003_bib0015","first-page":"2437","article-title":"The serotonin syndrome","volume":"356","author":"Boyer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxrep.2021.11.003_bib0020","series-title":"Product Information: WELLBUTRIN(R) Oral Tablets, Bupropion HCl Oral Tablets","year":"2011"},{"key":"10.1016\/j.toxrep.2021.11.003_bib0025","series-title":"Product Information: LEXAPRO(R) Oral Tablet, Oral Solution, Escitalopram Oxalate Tablet, Oral Solution","year":"2005"},{"key":"10.1016\/j.toxrep.2021.11.003_bib0030","series-title":"Product Information: TRINTELLIX Oral Tablets, Vortioxetine Oral Tablets","year":"2016"},{"issue":"4","key":"10.1016\/j.toxrep.2021.11.003_bib0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12245-010-0195-7","article-title":"The serotonin syndrome\u2014the need for physician\u2019s awareness","volume":"3","author":"Arora","year":"2010","journal-title":"Int. J. Emerg. Med."},{"issue":"7\u20138","key":"10.1016\/j.toxrep.2021.11.003_bib0040","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1345\/aph.10203","article-title":"Serotonin syndrome: early management with cyproheptadine","volume":"35","author":"McDaniel","year":"2001","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.toxrep.2021.11.003_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13181-019-00749-4","article-title":"Single-agent bupropion exposures: clinical characteristics and an atypical cause of serotonin toxicity","volume":"16","author":"Murray","year":"2020","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.toxrep.2021.11.003_bib0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-017-0612-7","article-title":"Vortioxetine: clinical pharmacokinetics and drug interactions","volume":"57","author":"Chen","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.toxrep.2021.11.003_bib0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S1092852900021027","article-title":"Serotonin syndrome associated with the use of escitalopram","volume":"12","author":"Huska","year":"2007","journal-title":"CNS Spectr."},{"issue":"6","key":"10.1016\/j.toxrep.2021.11.003_bib0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/emj.20.6.560","article-title":"Sustained release bupropion overdose: an important cause of prolonged symptoms after an overdose","volume":"20","author":"Jepsen","year":"2003","journal-title":"Emerg. Med. J."},{"issue":"5","key":"10.1016\/j.toxrep.2021.11.003_bib0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/JCP.0000000000000774","article-title":"Lurasidone-associated neuroleptic malignant syndrome","volume":"37","author":"Lee","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxrep.2021.11.003_bib0070","series-title":"Brain Disord. Crit. Illn.","first-page":"329","article-title":"Drug-induced encephalopathy","author":"M\u00e9garbane","year":"2013"},{"issue":"4","key":"10.1016\/j.toxrep.2021.11.003_bib0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006565-199508000-00012","article-title":"Cyproheptadine-induced central anticholinergic syndrome in a child: a case report","volume":"11","author":"Blaustein","year":"1995","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.toxrep.2021.11.003_bib0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650.2017.1370096","article-title":"Acute lamotrigine overdose: a systematic review of published adult and pediatric cases","volume":"56","author":"Alyahya","year":"2018","journal-title":"Clin. Toxicol. (Phila. Pa)"},{"key":"10.1016\/j.toxrep.2021.11.003_bib0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/2045125316656707","article-title":"Safety profile of lamotrigine in overdose","volume":"6","author":"Alabi","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.toxrep.2021.11.003_bib0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/15563650.2013.818685","article-title":"A case series of patients with lamotrigine toxicity at one center from 2003 to 2012","volume":"51","author":"Moore","year":"2013","journal-title":"Clin. Toxicol. (Phila. Pa)"}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750021001876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750021001876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:13:26Z","timestamp":1780416806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750021001876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":18,"alternative-id":["S2214750021001876"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2021.11.003","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escitalopram, bupropion, lurasidone, lamotrigine and possible vortioxetine overdose presented with serotonin syndrome and diffuse encephalopathy: A case report","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}